How much cash does Profound Medical generate?

Profound Medical (PROF) generated -$38.5M in operating cash flow over the trailing twelve months.

Where does Profound Medical's cash flow data come from?

Every line is extracted from Profound Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Profound Medical PROF Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	-$38.9M-21.7%	-$42.57M-53.0%	-$39.34M-31.4%	-$40.73M-47.2%	-$31.96M-14.8%
Depreciation and amortization	$350K-43.9%	$373K-47.2%	$471K-35.4%	$542K-27.4%	$624K-16.2%
Stock-based compensation	$5.55M+98.0%	$5.49M+113%	$4.55M+52.0%	$3.49M+7.5%	$2.8M-15.8%
Change in inventories	$2.96M+1,903%	$2.95M+550%	$2.24M+949%	$1.9M+22,441%	$148K+275%
Change in accounts payable	——	——	——	$1.87M+998%	$1.69M+278%
Change in deferred revenue	——	——	——	-$649K-682%	-$589K-1,871%
Change in income taxes payable/receivable	$33.5K—	$42K—	——	——	——
Amortization of intangible assets	$147K-34.7%	$187K-18.3%	$218K+8.2%	$214K+5.9%	$225K+11.1%
Change in receivables	——	——	——	——	——
Net cash from operating activities	-$38.51M-41.5%	-$38.21M-62.9%	-$37.52M-61.5%	-$34.73M-57.5%	-$27.21M-26.6%
Capital expenditures	——	$176K—	——	——	——
Purchases of intangible assets	——	$66K—	——	——	——
Net cash from investing activities	——	-$242K—	——	——	——
Repayments of debt	——	——	——	——	$1.65M+25.9%
Net cash from financing activities	——	——	——	——	——
Effect of exchange rate changes on cash	——	——	——	——	——
Net increase (decrease) in cash	$2.68M—	$2.69M—	-$2.38M—	——	——
Interest paid	——	——	——	——	——
Income taxes paid	——	——	$140K-44.4%	$143K-43.7%	$249K+85.8%
Amortization of capitalized software and acquired intangible assets	$147K-34.7%	$187K-18.3%	$218K+8.2%	$214K+5.9%	$225K+11.1%
Depreciation	$350K-43.9%	$373K-47.2%	$471K-35.4%	$542K-27.4%	$624K-16.2%
Increase (Decrease) in Accounts and Other Receivables	——	——	——	——	——
Increase Decrease In Deferred Income Tax Assets	-$16.5K-127%	-$26K-129%	$3.25K—	$32.5K—	$61.75K—
Deferred revenue	——	——	——	-$649K-682%	-$589K-1,871%
Increase Decrease In Prepaid Expense And Deposits Current	——	——	——	——	——
Interest And Accretion Expense	$20K-95.8%	$63K-89.5%	$191K-70.6%	$328K-52.2%	$479K-32.9%
Non Cash Lease Expense Adjustment	-$22K-161%	$37K-2.6%	$32K-29.3%	$36K-17.2%	$36K-19.6%
Payments to Acquire Intangible Assets	——	$66K—	——	——	——
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations	——	——	——	——	——
Income Taxes Paid, Net	——	——	$140K-44.4%	$143K-43.7%	$249K+85.8%
Free cash flow	——	-$38.38M—	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Profound Medical.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

How much cash does Profound Medical generate?: Profound Medical (PROF) generated -$38.5M in operating cash flow over the trailing twelve months.
Where does Profound Medical's cash flow data come from?: Every line is extracted from Profound Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.